Lite Strategy Market Cap

Lite Strategy has a market cap or net worth of $39.63 million as of May 19, 2026. Its market cap has increased by 191.43% in one year.

Market Cap

39.63M

Enterprise Value

32.09M

1-Year Change

191.43%

Ranking

#4715

Market Cap Chart

Since December 18, 2003, Lite Strategy's market cap has decreased from $424.10M to $39.63M, a decrease of -90.65%. That is a compound annual growth rate of -10.03%.

Market Cap History

Date	Market Cap	% Change
May 18, 2026	37.30M	-23.25%
Dec 31, 2025	48.60M	196.34%
Dec 31, 2024	16.40M	-57.51%
Dec 29, 2023	38.60M	18.77%
Dec 30, 2022	32.50M	-89.20%
Dec 31, 2021	301.00M	1.31%
Dec 31, 2020	297.10M	62.62%
Dec 31, 2019	182.70M	-2.72%
Dec 31, 2018	187.80M	141.70%
Dec 29, 2017	77.70M	46.60%
Dec 30, 2016	53.00M	-2.93%
Dec 31, 2015	54.60M	-40.85%
Dec 31, 2014	92.30M	-46.40%
Dec 31, 2013	172.20M	580.63%
Dec 31, 2012	25.30M	105.69%
Dec 30, 2011	12.30M	73.24%
Dec 31, 2010	7.10M	-86.19%
Dec 31, 2009	51.40M	-
Dec 31, 2008	51.40M	-74.17%
Dec 31, 2007	199.00M	2.58%
Dec 29, 2006	194.00M	-45.49%
Dec 30, 2005	355.90M	-30.12%
Dec 31, 2004	509.30M	-23.48%
Dec 31, 2003	665.60M	56.94%
Dec 18, 2003	424.10M	-

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Telomir Pharmaceuticals	41.64M
Nutriband	41.57M
Atossa Therapeutics	40.90M
Quantum BioPharma	39.31M
Plus Therapeutics	39.25M
Tevogen Bio Holdings	38.62M
INmune Bio	37.75M
Mereo BioPharma Group	37.59M

Market Cap Rankings